Nuclear Medicine
TERABAC
Name:
Terabac
Active Principle:
Sodium Iodide (131I)
Therapeutic Action:
It is indicated for the treatment of hyperthyroidism (diffuse toxic goiter or nodular multiple toxic goiter). Diagnosis:
– For the pre-therapeutic determination of the kinetics of radioactive iodine (determination of the storage and effective half-life in the thyroid gland by means of a two-phase radioactive iodine test)
– Calculation of the activity necessary for therapy. – Whole body scintigraphy for the follow-up of papillary or follicular thyroid carcinomas. Therapy
– Therapy of focal or disseminated Graves’ disease and thyroid autonom
– Therapy of papillary or follicular thyroid carcinomas and their metastases Sodium iodide (131I) therapy is often combined with surgical measures and a thyrostat in a combination treatment.
Línea
Nuclear Medicine
Sublínea
Radiation Therapy
TERABAC
Línea
Nuclear Medicine
Sublínea
Radiation Therapy
TERABAC
Nuclear Medicine
TERABAC
Name:
Terabac
Active Principle:
Sodium Iodide (131I)
Therapeutic Action:
It is indicated for the treatment of hyperthyroidism (diffuse toxic goiter or nodular multiple toxic goiter). Diagnosis:
– For the pre-therapeutic determination of the kinetics of radioactive iodine (determination of the storage and effective half-life in the thyroid gland by means of a two-phase radioactive iodine test)
– Calculation of the activity necessary for therapy. – Whole body scintigraphy for the follow-up of papillary or follicular thyroid carcinomas. Therapy
– Therapy of focal or disseminated Graves’ disease and thyroid autonom
– Therapy of papillary or follicular thyroid carcinomas and their metastases Sodium iodide (131I) therapy is often combined with surgical measures and a thyrostat in a combination treatment.
RELATED PRODUCTS
-
131I MIBG BACON (R&D)
131I MIBG BACON (R&D)It is indicated for the diagnosis and location of neuroendocrine tumors, pheochromocytoma, medullary thyroid cancer, primary neuroblastomas and their metastases, paragangliomas and thymomas... -
PSMA (R+D)
PSMA (R+D)It is indicated for the detection and evaluation of prostate cancer from the initial diagnosis to the monitoring of castration-resistant metastases. -
PYROPHOSPHATE
PYROPHOSPHATEIt is indicated for performing bone scintigraphy, detection of cardiac pathologies and "in vivo" and "in vitro" marking of erythrocytes. 1) In vivo, in vitro or in vivo/in vitro marking of red blood cells to... -
FLPET (R+D)
FLPET (R+D)It is indicated for the detection and evaluation of cell proliferation in lung, breast, colorectal, melanoma, soft tissue sarcoma and primary or metastatic brain tumors. It allows to predict the aggressiveness...